Related papers: Nine Recommendations for Decision Aid Implementati…
Clinical Decision Support Systems (CDSSs) provide reasoning and inquiry guidance for physicians, yet they face notable challenges, including high maintenance costs and low generalization capability. Recently, Large Language Models (LLMs)…
A critical challenge facing clinicians managing chronic disease interventions is sustaining long-run patient health given limited information and resources. Digital therapeutics (DTs) provide a cost-effective way to manage interventions at…
The automation technology is emerging, but the adoption rate of autonomous vehicles (AV) will largely depend upon how policymakers and the government address various challenges such as public acceptance and infrastructure development. This…
This paper proposes a new consensus model in participatory decision making. The model employs advice centrality approach by electing a leader and recommender named as Supra Decision Maker (SDM). A SDM has a role as a decision bench-marker…
Digital contact tracing has been deployed as a public health intervention to help suppress the spread of COVID-19 in many jurisdictions. However, most governments have struggled with low uptake and participation rates, limiting the…
Clinical decision support systems are software tools that help clinicians to make medical decisions. However, their acceptance by clinicians is usually rather low. A known problem is that they often require clinicians to manually enter lots…
We present the Multiple Criteria Decision Analysis Methods Selection Software (MCDA-MSS). This decision support system helps analysts answering a recurring question in decision science: Which is the most suitable Multiple Criteria Decision…
Purpose: This study investigates the dynamics of knowledge sharing in healthcare, exploring some of the factors that are more likely to influence the evolution of idea sharing and advice seeking in healthcare. Design/methodology/approach:…
Many patients with chronic diseases resort to multiple medications to relieve various symptoms, which raises concerns about the safety of multiple medication use, as severe drug-drug antagonism can lead to serious adverse effects or even…
Algorithmic decision support (ADS), using Machine-Learning-based AI, is becoming a major part of many processes. Organizations introduce ADS to improve decision-making and use available data, thereby possibly limiting deviations from the…
Large language models (LLMs) have been increasingly adopted to support patients' healthcare-seeking in recent years. While prior patient-centered studies have examined the capabilities and experience of LLM-based tools in specific…
Clinical decision support systems (CDSS) augmented with artificial intelligence (AI) models are emerging as potentially valuable tools in healthcare. Despite their promise, the development and implementation of these systems typically…
A key aspect of patient-focused drug development is identifying and measuring outcomes that are important to patients in clinical trials. Many medical conditions affect multiple symptom domains, and a consensus approach to determine the…
Many Artificial Intelligence systems depend on the agent's updating its beliefs about the world on the basis of experience. Experiments constitute one type of experience, so scientific methodology offers a natural environment for examining…
Much attention and concern has been raised recently about bias and the use of machine learning algorithms in healthcare, especially as it relates to perpetuating racial discrimination and health disparities. Following an initial system…
As large language models (LLMs) evolve from single-user assistants to active participants in civic and workplace deliberation, evaluating their effects on collective decision making becomes a governance challenge. We present two empirical…
Participatory Design (PD) methods are effective in understanding older adults' perspectives, concerns, and wishes and generating ideas for new intelligent aids. The aim of our study was first to map perceptions and explore the needs of…
Multidisciplinary team (MDT) consultations are the gold standard for cancer care decision-making, yet current practice lacks structured mechanisms for quantifying consensus and ensuring decision traceability. We introduce a Multi-Agent…
Phase I clinical trials are designed to test the safety (non-toxicity) of drugs and find the maximum tolerated dose (MTD). This task becomes significantly more challenging when multiple-drug dose-combinations (DC) are involved, due to the…
Low attendance levels in medical appointments have been associated with poor health outcomes and efficiency problems for service providers. To address this problem, healthcare managers could aim at improving attendance levels or minimizing…